Cargando…
Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro
[Image: see text] Introduction: Human double minute2 (hdm2) level increases in most human malignancies. Therefore, inhibition of tumor growth and also induction of radiosensitivity may be provided by hdm2 inhibitors. The effects of hdm2-siRNA on hdm2 protein expression, cell apoptosis rate, and radi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981254/ https://www.ncbi.nlm.nih.gov/pubmed/27525226 http://dx.doi.org/10.15171/bi.2016.13 |
_version_ | 1782447585525497856 |
---|---|
author | Pirayesh Islamian, Jalil Mohammadi, Mohsen Baradaran, Behzad Farajollahi, Alireza Aghamiri, Seyed Mahmoud Reza Asghari Jafarabadi, Mohammad Karami, Hadi Monfaredan, Amir Shanehbandi, Dariush |
author_facet | Pirayesh Islamian, Jalil Mohammadi, Mohsen Baradaran, Behzad Farajollahi, Alireza Aghamiri, Seyed Mahmoud Reza Asghari Jafarabadi, Mohammad Karami, Hadi Monfaredan, Amir Shanehbandi, Dariush |
author_sort | Pirayesh Islamian, Jalil |
collection | PubMed |
description | [Image: see text] Introduction: Human double minute2 (hdm2) level increases in most human malignancies. Therefore, inhibition of tumor growth and also induction of radiosensitivity may be provided by hdm2 inhibitors. The effects of hdm2-siRNA on hdm2 protein expression, cell apoptosis rate, and radiosensitivity of human esophageal squamous cell carcinoma (ESCC) were studied. Methods: The hdm2 gene was silenced in TE1, TE8, and TE11 ESCC cell lines using 200nM siRNA by liposomal transfection method followed by irradiation with 0.5, 1, 2, 4, and 6 Gy γ-rays in vitro. The gene expression levels were evaluated by real time PCR and Western Blotting methods. MTT, TUNEL, and also colony forming assays were used to compare the radiosensitivity of the cell lines before and after the treatments. Results: Hdm2-siRNA reduced the hdm2 protein as compared to the vehicle control and scrambled groups, and also increased the radiation-induced apoptosis especially in TE11 cells. The related dose reduction factors (DRFs) for the silenced TE1, TE8, and TE11 cells calculated to be 1.20, 1.30, and 2.75, respectively. Conclusion: Increasing radiosensitivity of tumor cells may be provided by silencing the oncogenes. |
format | Online Article Text |
id | pubmed-4981254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Tabriz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-49812542016-08-12 Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro Pirayesh Islamian, Jalil Mohammadi, Mohsen Baradaran, Behzad Farajollahi, Alireza Aghamiri, Seyed Mahmoud Reza Asghari Jafarabadi, Mohammad Karami, Hadi Monfaredan, Amir Shanehbandi, Dariush Bioimpacts Original Article [Image: see text] Introduction: Human double minute2 (hdm2) level increases in most human malignancies. Therefore, inhibition of tumor growth and also induction of radiosensitivity may be provided by hdm2 inhibitors. The effects of hdm2-siRNA on hdm2 protein expression, cell apoptosis rate, and radiosensitivity of human esophageal squamous cell carcinoma (ESCC) were studied. Methods: The hdm2 gene was silenced in TE1, TE8, and TE11 ESCC cell lines using 200nM siRNA by liposomal transfection method followed by irradiation with 0.5, 1, 2, 4, and 6 Gy γ-rays in vitro. The gene expression levels were evaluated by real time PCR and Western Blotting methods. MTT, TUNEL, and also colony forming assays were used to compare the radiosensitivity of the cell lines before and after the treatments. Results: Hdm2-siRNA reduced the hdm2 protein as compared to the vehicle control and scrambled groups, and also increased the radiation-induced apoptosis especially in TE11 cells. The related dose reduction factors (DRFs) for the silenced TE1, TE8, and TE11 cells calculated to be 1.20, 1.30, and 2.75, respectively. Conclusion: Increasing radiosensitivity of tumor cells may be provided by silencing the oncogenes. Tabriz University of Medical Sciences 2016 2016-06-28 /pmc/articles/PMC4981254/ /pubmed/27525226 http://dx.doi.org/10.15171/bi.2016.13 Text en © 2016 The Author(s) This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
spellingShingle | Original Article Pirayesh Islamian, Jalil Mohammadi, Mohsen Baradaran, Behzad Farajollahi, Alireza Aghamiri, Seyed Mahmoud Reza Asghari Jafarabadi, Mohammad Karami, Hadi Monfaredan, Amir Shanehbandi, Dariush Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro |
title | Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro |
title_full | Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro |
title_fullStr | Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro |
title_full_unstemmed | Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro |
title_short | Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro |
title_sort | enhancing radiosensitivity of te1, te8, and te 11 esophageal squamous carcinoma cell lines by hdm2-sirna targeted gene therapy in vitro |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981254/ https://www.ncbi.nlm.nih.gov/pubmed/27525226 http://dx.doi.org/10.15171/bi.2016.13 |
work_keys_str_mv | AT pirayeshislamianjalil enhancingradiosensitivityofte1te8andte11esophagealsquamouscarcinomacelllinesbyhdm2sirnatargetedgenetherapyinvitro AT mohammadimohsen enhancingradiosensitivityofte1te8andte11esophagealsquamouscarcinomacelllinesbyhdm2sirnatargetedgenetherapyinvitro AT baradaranbehzad enhancingradiosensitivityofte1te8andte11esophagealsquamouscarcinomacelllinesbyhdm2sirnatargetedgenetherapyinvitro AT farajollahialireza enhancingradiosensitivityofte1te8andte11esophagealsquamouscarcinomacelllinesbyhdm2sirnatargetedgenetherapyinvitro AT aghamiriseyedmahmoudreza enhancingradiosensitivityofte1te8andte11esophagealsquamouscarcinomacelllinesbyhdm2sirnatargetedgenetherapyinvitro AT asgharijafarabadimohammad enhancingradiosensitivityofte1te8andte11esophagealsquamouscarcinomacelllinesbyhdm2sirnatargetedgenetherapyinvitro AT karamihadi enhancingradiosensitivityofte1te8andte11esophagealsquamouscarcinomacelllinesbyhdm2sirnatargetedgenetherapyinvitro AT monfaredanamir enhancingradiosensitivityofte1te8andte11esophagealsquamouscarcinomacelllinesbyhdm2sirnatargetedgenetherapyinvitro AT shanehbandidariush enhancingradiosensitivityofte1te8andte11esophagealsquamouscarcinomacelllinesbyhdm2sirnatargetedgenetherapyinvitro |